# Regular Cannabinoid Use and Inflammatory Biomarkers: A Meta-Analysis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-inflammation-systematic-review/ > **Published:** 2026-03-20T17:44:07-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:54:51-04:00 > **Clinical Summary:** Explore cannabinoids and inflammation systematic review findings on inflammatory biomarkers and clinical implications of regular cannabinoid use. --- CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic InflammationBiomarkersMeta-AnalysisThcCbd Journal Brain, behavior, and immunity Study Type Randomized Trial Population Human participants Why This Matters This [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and meta-analysis addresses a critical gap in understanding cannabis’s inflammatory effects across healthy and psychiatric populations. With [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) rising for both medical and recreational purposes, clinicians need evidence-based guidance on how cannabinoids affect systemic inflammation. Clinical Summary This comprehensive meta-analysis of 46 studies involving 54,382 participants examined peripheral inflammatory biomarkers in cannabinoid users versus non-users. The analysis included 190 effect sizes from observational studies, prospective studies, and randomized controlled trials. Observational data suggested [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was associated with higher levels of anti-inflammatory markers, though the clinical significance and causality remain unclear given the heterogeneous study designs and populations included. Dr. Caplan’s Take “While intriguing, this meta-analysis highlights how much we still don’t understand about cannabis and inflammation. The mixed findings across study types reinforce that we cannot yet make definitive claims about cannabinoids’ [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) in clinical practice.” Clinical Perspective 🧠 Clinicians should interpret these findings cautiously and avoid recommending cannabis solely for anti-inflammatory purposes based on this evidence. Patients asking about cannabis for inflammatory conditions should understand that while some biomarker associations exist, we lack sufficient clinical evidence to establish therapeutic benefit or optimal dosing protocols. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Regular%20cannabinoid%20use%20and%20inflammatory%20biomarkers%3A%20Systematic%20review%20and%20hiera...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41740869/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41740869/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Regular%20cannabinoid%20use%20and%20inflammatory%20biomarkers%3A%20Systematic%20review%20and%20hiera...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41740869/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41740869/](https://pubmed.ncbi.nlm.nih.gov/41740869/) Table of Contents - [FAQ](#FAQ)[Does regular cannabis use lower inflammation in the body?](#Does_regular_cannabis_use_lower_inflammation_in_the_body) - [How many studies were included in this cannabis inflammation meta-analysis?](#How_many_studies_were_included_in_this_cannabis_inflammation_meta-analysis) - [Which groups of people did this inflammation review look at?](#Which_groups_of_people_did_this_inflammation_review_look_at) - [Should cannabis be used to treat inflammatory conditions based on this study?](#Should_cannabis_be_used_to_treat_inflammatory_conditions_based_on_this_study) - [Related](#Related) ## FAQ ### Does regular cannabis use lower inflammation in the body? The evidence is unclear. In this meta-analysis, observational data suggested that cannabis use was associated with higher levels of anti-inflammatory markers. However, the clinical significance of this finding and whether cannabis actually causes these changes remain unclear, given the mixed study designs and populations included. ### How many studies were included in this cannabis inflammation meta-analysis? The analysis pooled 46 studies involving 54,382 participants and was published in Brain, Behavior, and Immunity. It included 190 effect sizes drawn from observational studies, prospective studies and randomized controlled trials, comparing peripheral inflammatory biomarkers in cannabinoid users with those in non-users. ### Which groups of people did this inflammation review look at? The review examined cannabis’s inflammatory effects across both healthy and psychiatric populations. It addressed a gap in understanding how cannabinoids affect systemic inflammation at a time when cannabis use is rising for both medical and recreational purposes. ### Should cannabis be used to treat inflammatory conditions based on this study? Not on this evidence alone. Although some biomarker associations were found, there is not yet sufficient clinical evidence to establish a therapeutic benefit or optimal dosing for cannabis in inflammatory conditions. The findings are best interpreted cautiously rather than as a reason to use cannabis solely for anti-inflammatory purposes. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Regular cannabinoid use and inflammatory biomarkers: [Systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and hierarchical meta-analysis.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41740869/”, “about”: “brain behavior immunity randomized trial regular”, “isPartOf”: “Brain, behavior, and immunity”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids and Inflammation: A Systematic Review of Clinical Evidence](https://cedclinic.com/cannabinoid-use-inflammatory-biomarkers-review/) A detailed review of clinical evidence on cannabinoids' effects on inflammation, complementing insights from the current meta-analysis. [Read the Review](https://cedclinic.com/cannabinoid-use-inflammatory-biomarkers-review/) [Cannabinoid Use Linked to Both Pro- and Anti-Inflammatory Effects](https://cedclinic.com/cannabinoid-effects-on-inflammation-complex-bidirectional-review/) Explore a massive review highlighting the dual inflammatory effects of cannabinoid use across different populations. [Explore Findings](https://cedclinic.com/cannabinoid-effects-on-inflammation-complex-bidirectional-review/) [Cannabinoid Formulations for Anxiety and Tourette Syndrome](https://cedclinic.com/cannabinoid-formulations-anxiety-treatment/) Learn about [cannabinoid formulations](https://cedclinic.com/brazil-cannabis-regulatory-framework-new-medical-rules/) used in anxiety and Tourette syndrome, providing [clinical context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) for cannabinoid applications. [Learn More](https://cedclinic.com/cannabinoid-formulations-anxiety-treatment/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).